BHRT may improve libido and sexual function when low desire, arousal changes, vaginal dryness, painful sex, orgasm changes, or reduced sexual satisfaction are related to hormone changes. In women, estrogen can support vaginal and urinary tissue, blood flow, lubrication, comfort, and sexual response, while testosterone may help sexual desire in select patients when other causes have been evaluated. Progesterone may support sleep and mood for some women, which can indirectly affect libido. BHRT is not a guaranteed fix for low libido because sexual function is also influenced by stress, sleep, relationship dynamics, mood, pain, medications, thyroid function, blood sugar, trauma history, body image, and overall health. The best plan identifies which part of sexual function is affected and why.

Key Points

• BHRT may help when hormones are part of the problem. Low estrogen, fluctuating perimenopause hormones, menopause, surgical menopause, low testosterone, poor sleep, and vaginal tissue changes can all affect libido and sexual function.
• Libido and sexual function are not the same thing. Libido means desire or interest in sex. Sexual function also includes arousal, lubrication, comfort, orgasm, pelvic floor function, emotional connection, and satisfaction.
• Estrogen can improve vaginal and urinary symptoms. Systemic or local estrogen may help vaginal dryness, painful sex, urinary urgency, recurrent urinary discomfort, and tissue thinning related to menopause.
• Testosterone may help select women with low desire. Testosterone therapy may be considered for persistent low sexual desire that causes distress after other contributors have been evaluated. Women should be dosed conservatively and monitored carefully.
• Sleep and mood matter. Hot flashes, night sweats, insomnia, anxiety, irritability, and fatigue can reduce desire. BHRT may indirectly support libido when it improves sleep and emotional resilience.
• Medications can affect sexual function. Some antidepressants, birth control, blood pressure medications, pain medications, sleep medications, and other prescriptions can reduce desire, arousal, lubrication, or orgasm quality.
• Safe hormone care requires monitoring. BHRT should be based on symptoms, medical history, hormone patterns, risk screening, and follow-up, not on chasing high hormone levels.

Understanding Libido And Sexual Function

Low libido is one of the most common reasons people ask about BHRT, especially during perimenopause and menopause. Many women describe feeling like their desire “disappeared,” even if their relationship is healthy and they still want to want sex.

Sexual function has several parts. Desire is the interest in sex. Arousal is the body’s physical response. Lubrication helps comfort. Orgasm depends on blood flow, nerve function, pelvic floor function, mood, safety, and stimulation. Sexual satisfaction includes emotional connection, pleasure, comfort, and feeling present.

Hormones can affect all of these areas, but they are not the only factor. A person may have low desire because of vaginal pain, relationship stress, poor sleep, depression, anxiety, body image concerns, trauma history, medications, fatigue, or resentment from carrying too much mental load.

This is why the first question should not be, “Which hormone is low?” The first question should be, “What part of sexual function changed, when did it change, and what else changed around the same time?”

When the pattern points to perimenopause, menopause, surgical menopause, low estrogen, low testosterone, painful sex, or poor sleep from hormone changes, BHRT may be part of the solution.

How Estrogen Affects Sexual Function

Estrogen helps maintain the health of vaginal, vulvar, urinary, and pelvic tissues. When estrogen declines, tissues can become thinner, drier, less elastic, more sensitive, and more prone to irritation.

Low estrogen may contribute to vaginal dryness, burning, itching, painful sex, tearing, urinary urgency, recurrent urinary discomfort, and reduced lubrication. These symptoms are often part of genitourinary syndrome of menopause.

When sex becomes painful, desire often drops. This is not a lack of attraction or effort; it is the body learning to avoid discomfort. Treating vaginal dryness and tissue changes can make intimacy feel safer and more comfortable again.

Local vaginal estrogen may be helpful for vaginal and urinary symptoms because it targets the tissues directly. It may be used by many women even when systemic hormone therapy is not needed, though individual safety history still matters.

Systemic estradiol may also help sexual function when low libido is part of a broader menopause pattern that includes hot flashes, night sweats, poor sleep, mood changes, brain fog, and vaginal symptoms.

How Testosterone May Affect Libido

Women make testosterone too, although in much lower amounts than men. Testosterone can influence sexual desire, arousal, orgasm, motivation, energy, muscle, and overall vitality.

Testosterone therapy may be considered for select women with persistent low sexual desire that causes distress, especially when other contributors have been evaluated. It is not appropriate to assume every woman with low libido needs testosterone.

Low desire can come from vaginal pain, low estrogen, poor sleep, relationship stress, depression, anxiety, trauma, medications, thyroid dysfunction, low ferritin, insulin resistance, or chronic stress. These should be reviewed before starting testosterone.

Women should not be dosed like men. Testosterone dosing should be conservative and monitored to avoid excessive androgen exposure.

Possible signs of too much testosterone in women include acne, oily skin, unwanted facial or body hair, scalp hair thinning, irritability, sleep disruption, mood changes, voice changes, or clitoral enlargement. Some side effects may not fully reverse if exposure is excessive or prolonged.

How Progesterone, Sleep, And Mood Affect Desire

Progesterone can affect sleep, mood, and nervous system regulation. For some women, oral micronized progesterone taken at bedtime supports deeper sleep or a calmer evening pattern.

Better sleep can improve libido indirectly. When someone is exhausted, anxious, overheated at night, or waking repeatedly, sexual desire often becomes a lower priority.

Progesterone may be especially relevant during perimenopause, when ovulation becomes less consistent and progesterone patterns may decline or fluctuate. Some women experience worse PMS, anxiety, insomnia, breast tenderness, or mood swings during this transition.

However, progesterone does not feel good for everyone. Some people feel groggy, flat, bloated, dizzy, irritable, or emotionally low on certain doses or routes.

If systemic estrogen is used and the uterus is present, progesterone or another appropriate progestogen is usually needed to protect the uterine lining. Progesterone may also be appropriate for some women without a uterus when it supports sleep, mood, or hormone balance, but the reason is different and should be individualized.

When BHRT May Improve Libido Most

BHRT may be more likely to help libido when low desire appears with other hormone-related symptoms. These may include hot flashes, night sweats, insomnia, irregular cycles, vaginal dryness, painful sex, urinary symptoms, mood swings, brain fog, low motivation, or menopause-related body changes.

It may also help when sexual function changed after surgical menopause, chemotherapy-induced menopause, early menopause, stopping hormone therapy, or a major perimenopause shift.

For some women, local vaginal estrogen improves comfort enough that desire begins to return. For others, systemic estradiol improves sleep and hot flashes, which indirectly improves intimacy. In selected women, testosterone may improve desire when low sexual desire remains distressing after other contributors are addressed.

In men, testosterone therapy may improve libido and erectile function in some cases when symptoms of testosterone deficiency are present and low testosterone is confirmed with proper testing. Erectile dysfunction can also come from vascular disease, diabetes, medications, stress, sleep apnea, alcohol, depression, or nerve issues, so evaluation matters.

BHRT works best when it is part of a broader plan that also addresses sleep, stress, pain, relationship factors, medications, metabolic health, thyroid function, and emotional well-being.

When BHRT May Not Be Enough

BHRT may not fully improve libido if the main driver is not hormonal. Desire can be affected by chronic stress, relationship disconnection, resentment, pain, trauma history, depression, anxiety, poor sleep, caregiving overload, or feeling emotionally unsafe.

Medications are a common contributor. Some antidepressants, especially SSRIs and SNRIs, can reduce desire, arousal, or orgasm. Some blood pressure medications, hormonal contraceptives, pain medications, sleep medications, and other prescriptions can also affect sexual function.

Thyroid dysfunction, low ferritin, low B12, low vitamin D, insulin resistance, pelvic floor dysfunction, endometriosis, vulvodynia, recurrent infections, bladder pain, and gut inflammation can also affect libido and sexual comfort.

Relationship and communication patterns matter too. If sex has become painful, pressured, disconnected, or associated with anxiety, the body may need time, safety, and sometimes pelvic floor therapy or sex therapy to rebuild desire.

A complete plan may include BHRT, local vaginal therapy, pelvic floor physical therapy, counseling, medication review, sleep care, blood sugar support, thyroid care, nutrition support, or treatment for pain conditions.

Testing Before BHRT For Libido Concerns

Testing should be guided by symptoms, sex, age, cycle status, menopause stage, medications, and medical history. Hormone labs can help, but they are not the only useful information.

For women, testing may include estradiol, progesterone, FSH, LH, total and free testosterone, SHBG, DHEA-S, thyroid markers, thyroid antibodies, CBC, CMP, fasting glucose, fasting insulin, A1C, lipids, ferritin, iron studies, B12, vitamin D, and inflammatory markers when appropriate.

In perimenopause, hormone levels can fluctuate significantly, so a single normal lab result does not always rule out hormone-related symptoms. Cycle timing and symptom pattern matter.

For men, testing usually includes morning total testosterone, free testosterone, SHBG, LH, FSH, prolactin, CBC, CMP, lipids, glucose markers, A1C, and prostate-related screening when appropriate. Testosterone should often be checked more than once before diagnosing deficiency.

A libido evaluation should also include medication review, sleep review, mood screening, pain history, relationship context, pelvic symptoms, vaginal or urinary symptoms, and metabolic health.

FDA-Approved And Compounded BHRT Options

Bioidentical hormones can be available as FDA-approved medications or as compounded prescriptions. Bioidentical describes the hormone molecule itself, not whether the medication is commercial or compounded.

FDA-approved bioidentical options may include estradiol patches, gels, sprays, vaginal products, and oral micronized progesterone. These products have standardized dosing and manufacturing oversight.

Compounded BHRT may be used when a patient needs a customized dose, route, combination, or formulation that is not commercially available. This may include certain creams, capsules, troches, vaginal preparations, or testosterone formulations.

Estradiol, progesterone, and testosterone can exist as FDA-approved medications or as ingredients used in compounded prescriptions. The final compounded formulation is customized and is not reviewed by FDA in the same way as a commercially manufactured drug.

Compounded therapy can be appropriate in selected cases, but it should not be assumed to be safer or better simply because it is customized. Pharmacy quality, dosing, route, and monitoring matter.

How It Works / What’s Involved

A BHRT evaluation for libido starts with a detailed history. Your provider should ask what changed, when it changed, whether desire, arousal, lubrication, pain, orgasm, or satisfaction is the main issue, and whether symptoms began with perimenopause, menopause, postpartum changes, surgery, medication changes, stress, or illness.

Your provider should also review hot flashes, night sweats, sleep, mood, vaginal dryness, painful sex, urinary symptoms, menstrual changes, medications, thyroid symptoms, blood sugar symptoms, relationship stress, trauma history, and pelvic pain.

If BHRT is appropriate, the plan may include systemic estradiol, oral micronized progesterone, local vaginal estrogen, testosterone in select cases, non-hormonal options, pelvic floor therapy, medication review, sleep support, or mental health support.

Follow-up should track libido, arousal, comfort, lubrication, orgasm, mood, sleep, vaginal or urinary symptoms, side effects, bleeding pattern, skin changes, hair changes, breast symptoms, and hormone levels when appropriate.

The goal is not to force desire or chase high hormone levels. The goal is to improve comfort, confidence, pleasure, safety, and overall quality of life.

Who It’s For And Who Should Be Cautious

BHRT may be appropriate for women whose low libido or sexual function changes appear during perimenopause, menopause, surgical menopause, or other hormone shifts, especially when symptoms include vaginal dryness, painful sex, hot flashes, night sweats, poor sleep, mood changes, or low motivation.

Local vaginal estrogen may be especially helpful for women whose main concern is dryness, burning, painful sex, urinary urgency, or recurrent urinary discomfort related to menopause.

Testosterone may be considered for select women with persistent low sexual desire that causes distress after other causes have been evaluated. It should be used carefully and monitored for androgenic side effects.

Men may be candidates for testosterone therapy when symptoms of testosterone deficiency are present and consistently low testosterone is confirmed with proper testing. Men with fertility goals, sleep apnea, prostate concerns, elevated red blood cell count, or high cardiovascular risk need careful evaluation.

People who should be cautious with systemic hormone therapy include those with unexplained bleeding, bleeding after menopause, cancer history, clotting disorders, active liver disease, uncontrolled blood pressure, high cardiovascular risk, migraines with aura, severe mood symptoms, or complex medication histories.

Risks, Side Effects, and Monitoring

Possible estrogen side effects include breast tenderness, bloating, nausea, headaches, fluid retention, mood changes, skin irritation from patches or creams, or spotting. Abnormal bleeding, heavy bleeding, persistent bleeding, or bleeding after menopause should be evaluated.

Local vaginal estrogen is often low-dose and targeted, but side effects can still include irritation, discharge, spotting, or breast tenderness in some people. Any unexpected bleeding should be discussed with a clinician.

Progesterone may cause sleepiness, dizziness, mood changes, bloating, breast tenderness, vivid dreams, or changes in bleeding patterns. Progestins are synthetic progesterone-like medications, while micronized progesterone is bioidentical to the progesterone the body naturally makes. These can have different effects and different risk profiles.

Testosterone side effects may include acne, oily skin, unwanted facial or body hair, scalp hair thinning, irritability, sleep disruption, libido changes, mood changes, voice changes, or clitoral enlargement in women if exposure is excessive. In men, testosterone therapy can also increase red blood cell count and suppress fertility.

Monitoring should include libido, sexual comfort, vaginal and urinary symptoms, pain, mood, sleep, acne, hair changes, bleeding pattern, breast symptoms, blood pressure, labs when appropriate, and age-appropriate screening.

Safety

Seek urgent medical care right away for chest pain, severe shortness of breath, fainting, one-sided weakness or numbness, sudden severe headache, vision changes, severe leg swelling or calf pain, coughing blood, severe abdominal pain, suicidal thoughts, or confusion. These symptoms should not be treated as routine hormone side effects.

Call your provider for non-urgent but important concerns such as abnormal bleeding, bleeding after menopause, breast changes, pelvic pain, painful sex that does not improve, recurrent urinary symptoms, worsening mood, acne, unwanted hair growth, scalp hair thinning, voice changes, sleep disruption, or symptoms that worsen after starting or changing BHRT.

Do not start testosterone, estrogen, progesterone, hormone pellets, sexual function medications, high-dose supplements, or compounded hormone products without appropriate medical guidance. Safe treatment depends on your symptoms, medical history, medications, risk factors, and the full sexual health picture.

Sources and Citations

• Global Consensus Position Statement on the Use of Testosterone Therapy for Women — The Journal of Clinical Endocrinology & Metabolism / PubMed
• Genitourinary Syndrome of Menopause Guideline — American Urological Association
• The 2025 Menopausal Hormone Therapy Guidelines — PMC
• The 2022 Hormone Therapy Position Statement — Menopause / PubMed
• Hormone Replacement Therapy — NCBI Bookshelf
• Testosterone Deficiency Guideline — American Urological Association